| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 441,824 shares worth roughly $17.0M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | - | - | |
| Dir | 448.0K | - | - | |
| Dir | 130.1K | - | - | |
| Dir | 127.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | Nazzi Gianfranco | EVP, International Markets | Sale+OE | 21,635 | $12.72 | $275,216.67 | -26.4% | |
| Feb 9, 2021 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 20,694 | $12.69 | $262,699.98 | -20.9% | |
| Sep 9, 2020 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 333 | $8.98 | $2,991.81 | -3.0% | |
| Aug 11, 2020 | Crane Rosemary A | Director | Sale+OE | 2,860 | $11.90 | $34,037.72 | -7.9% | |
| Mar 17, 2020 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 616 | $7.17 | $4,417.58 | -5.6% | |
| Mar 17, 2020 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 944 | $7.16 | $6,762.34 | -100% | |
| Mar 17, 2020 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 514 | $7.16 | $3,682.04 | -1.1% | |
| Mar 17, 2020 | Nazzi Gianfranco | EVP, International Markets | Sale+OE | 345 | $7.17 | $2,474.13 | -1.7% | |
| Mar 17, 2020 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 470 | $7.16 | $3,366.85 | -3.1% | |
| Mar 17, 2020 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 2,359 | $7.16 | $16,898.70 | -44.2% |